Understanding the T cell immune response in SARS coronavirus infection
The severe acute respiratory syndrome (SARS) epidemic started in late 2002 and swiftly spread across 5 continents with a mortality rate of around 10%. Although the epidemic was eventually controlled through the implementation of strict quarantine measures, there continues a need to investigate the S...
Main Authors: | Hsueh-Ling Janice Oh, Samuel Ken-En Gan, Antonio Bertoletti, Yee-Joo Tan |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2012-07-01
|
Series: | Emerging Microbes and Infections |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1038/emi.2012.26 |
Similar Items
-
Development of multi-epitope peptide-based vaccines against SARS-CoV-2
by: Hui Xuan Lim, et al.
Published: (2021-03-01) -
Profiling CD8+ T cell epitopes of COVID-19 convalescents reveals reduced cellular immune responses to SARS-CoV-2 variants
by: Hang Zhang, et al.
Published: (2021-09-01) -
Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm
by: Carolina Boni, et al.
Published: (2021-09-01) -
Designing structure and <i>E. coli</i> strain-producer bearing SARS-CoV-2 N, S, M, E protein-related sequence antigen
by: Vladimir V. Kopat, et al.
Published: (2023-10-01) -
In Silico Analysis Predicts a Limited Impact of SARS-CoV-2 Variants on CD8 T Cell Recognition
by: Olga I. Isaeva, et al.
Published: (2022-04-01)